What is a substitute for Berodual for inhalation?

Today, the pharmaceutical market offers many drugs that have similar medicinal properties. This also applies to inhalation agents that contain bronchodilators and bronchial beta2-adrenoreceptor stimulants.

Berodual analogues are selected by the attending physician. The doctor evaluates the patient's age and condition, the severity of the disease. The most similar in composition and effect on the body medications in inhalation forms include:

• Foradil is a prolonged-release bronchodilating drug. Contains the active substance formoterol fumarate, a selective beta2-adrenoreceptor agonist. Dilates the bronchi in case of irreversible airway obstruction. Provides a local anti-inflammatory effect, preventing swelling and accumulation of inflammatory cells. The therapeutic effect develops within 1-3 minutes and lasts for 10-12 hours.
• Tevacomb is a bronchodilator drug. Contains salmeterol (as salmeterol xinafoate) and fluticasone propionate. Effectively relieves bronchospasms, used in the treatment of bronchial asthma, chronic obstructive pulmonary disease and other pathologies of the respiratory system.
• Foster is a combination drug containing the synthetic glucocorticosteroid beclomethasone and the selective β-adrenoreceptor agonist formoterol. The drug has proven itself in the treatment of bronchial asthma.
• Seretide is a combined anti-asthmatic drug containing fluticasone propionate and salmeterol. It belongs to the pharmacological group of selective beta2-adenoceptor agonists. When used by inhalation, it helps to relax the smooth muscles of the bronchi, preventing the development of bronchospasms. It has a local anti-inflammatory effect, reduces the symptoms and frequency of attacks of bronchial asthma.
• Ipradual is an anti-asthmatic drug containing ipratropium bromide, which has an anticholinergic effect, and fenoterol hydrobromide, a beta-adrenergic agonist. It inhibits vagal reflexes due to antagonistic interaction with acetylcholine, a mediator that ensures the transmission of the vagus nerve impulse. It relaxes bronchial and vascular smooth muscles. It protects against bronchoconstriction stimulants (cold air, allergens, some drugs). It is used in the treatment of respiratory diseases.
• Freeway Combi is a drug from the pharmaceutical group of adrenergic agents in combination with anticholinergic components. Contains two active ingredients: ipratropium bromide and fenoterol hydrobromide. It has a combined spasmolytic effect on the bronchial muscles. It is effective in diseases with impaired airway patency.

All of the above drugs are intended for inhalation use.

Cheap analogues

Berodual is a popular drug with bronchodilating properties. It is used for obstructive respiratory diseases and in the treatment of bronchial asthma. The drug has a number of analogues that are not inferior to it in effectiveness, but have a more affordable price. Cheap analogues of Berodual include:

1. Seretide is a glucocorticosteroid from the pharmacological group of anti-asthmatic, beta-adrenomimetic and bronchodilator drugs. Contains salmeterol and fluticasone propionate. It is used to treat bronchial asthma and obstructive airway diseases. It is available in aerosol form.
2. Salbutamol is a beta-adrenergic receptor stimulant, contains salbutamol sulfate. Stimulates beta-adrenergic receptors of the bronchi, providing a pronounced and prolonged (5-8 hours) bronchodilator effect. Prevents and relieves bronchospasms, attacks of bronchial asthma.
3. Ipratropium-native is a bronchodilator containing ipratropium bromide and fenoterol. It is used in the treatment of bronchial asthma, chronic bronchitis, pulmonary emphysema and other respiratory diseases.
4. Pulmicort is a glucocorticosteroid with the active component budesonide. It is prescribed for monotherapy and combined treatment of obstructive pulmonary disease, false croup, and stenosing laryngotracheitis. It can also be used as an adjuvant in bronchial asthma.
5. Berotek is a selective beta2-adrenergic agonist with the active component fenoterol hydrobromide. It is used for attacks of bronchial asthma caused by various factors. Berotek is effective in the treatment of conditions accompanied by narrowing of the airways.
6. Atrovent is an anti-asthmatic drug from the pharmacological group of beta-adrenergic receptor stimulants. Contains the active substance m-cholinergic receptor blocker - ipratropium bromide. It is used in chronic obstructive pulmonary disease with and without emphysema, in bronchial asthma with cardiovascular pathologies, bronchospasms. The drug can be used in diagnosing the reversibility of broncho-obstruction, as well as in bronchospasms during surgical interventions and in preparation for aerosol administration of potent drugs.

The above-mentioned medications are available in the form of an aerosol and a solution for inhalation. Despite the fact that they have a mechanism of action similar to berodual, all medications and their dosage should be prescribed only by the attending physician.

Berotek or berodual?

Both drugs belong to the pharmacological group of bronchodilator inhalation agents. They have a similar mechanism of action and indications for use: spasms of the respiratory tract, their edema and shortness of breath in various diseases of the respiratory system.

The therapeutic effect of Berotek develops within 5 minutes, while that of Berodual is 10-15 minutes. The therapeutic effect of the first lasts for 6 hours, while that of the second drug lasts for 3-4 hours. Berotek has more contraindications and side effects, but can be used to treat patients from the age of four

Let's take a closer look at the features of using Berotek:

Berotek is a drug from the group of selective beta2-adrenomimetics. Contains the active substance - fenoterol hydrobromide. When used by inhalation, the therapeutic effect develops within 5 minutes and lasts for 3-5 hours. About 17% of the active component enters the systemic bloodstream. It penetrates the hematoplacental barrier and is excreted in breast milk.

• Indications for use: attacks of bronchial asthma of various origins, chronic obstructive bronchitis and other diseases of the respiratory system with breathing disorders. The duration of inhalations and the necessary dosage are determined by the attending physician.
• Side effects: nausea, vomiting, tachycardia, heart rhythm disturbances. Headaches and dizziness, nervousness, weakness. Local irritation of mucous membranes, allergic reactions.
• Contraindications: hypersensitivity to the components of the drug, hypertrophic obstructive cardiomyopathy, tachyarrhythmia. Not recommended for use during pregnancy and lactation, for patients under 4 years of age.
• Overdose: tachyarrhythmia, tremor, changes in blood pressure, heart rhythm disturbances, hyperemia of the upper body. Treatment is carried out with specific antidotes - beta-adrenergic receptor blockers.

Release form: 10 ml aerosol in a can with a dosing device.

When choosing which drug is better, you should take into account the indications for its use. Both drugs have a symptomatic effect and do not eliminate the root cause of the painful condition. Berotek is effective for mild asthma attacks. Berodual has a stronger combined composition and is used for prolonged and chronic bronchospasms.

[ 1 ]

Ambrobene or Berodual?

Berodual and Ambrobene belong to different pharmacological groups and have different mechanisms of action. Berodual has a pronounced bronchodilator (expanding the lumen of the bronchi) effect. Belongs to the pharmacological group of beta-adrenergic receptor stimulants.

Ambrobene is a mucolytic with secretomotor, secretolytic and expectorant properties. Stimulates serous cells of the bronchial mucosa glands, increases the content of mucous secretion and promotes its removal from the body. Normalizes the ratio of serous and mucous components of sputum. The drug also stimulates prenatal lung development in newborns and premature babies.

Very often, patients are prescribed a treatment regimen that consists of inhalations of each drug separately or a mixture of them. The drugs complement each other, so choosing a more effective or better drug is not correct.

Atrovent or Berodual?

Atrovent is used for COPD and asthma, and Berodual effectively dilates the bronchi, facilitating the breathing process. Both drugs belong to the pharmacological group of beta-adrenergic receptor stimulants.

Atrovent contains an active component - itratropium bromide, which is a blocker of m-cholinergic receptors. It has a bronchodilating effect, prevents reflex spasms of the bronchi due to the influence of various factors and reduces the secretion of the glands of the bronchial mucosa. The therapeutic effect after inhalation develops within 10 minutes and lasts for 4-6 hours.

• Indications for use: chronic obstructive pulmonary disease with/without emphysematous changes, bronchial asthma, bronchospasms associated with colds and infectious diseases, preparation for the administration of aerosol drugs, bronchospasms during surgical interventions, diagnostic procedures.
• Method of application: in the form of inhalations 3-5 times a day for adults, 1-2 times a day for children. The duration of treatment depends on the therapeutic is effective in the first days, so it is determined by the attending physician.
• Side effects: dry mouth, nausea, thickening of sputum, swelling of the tongue, stomatitis, headaches, tachycardia, urinary retention, decreased motor functions of the gastrointestinal tract, glaucoma, urticaria, irritation of the nasal mucosa, anaphylactic shock. Overdose has similar signs, treatment is symptomatic.
• Contraindications: intolerance to the components of the drug, pregnancy (first trimester) and lactation. It is prescribed with caution in case of closed-angle glaucoma, prostatic hyperplasia, cystic fibrosis.

Release form: solution for inhalation and aerosol in 20 ml cans for 200 injections.

When choosing between Atrovent and Berodual for obstructive pulmonary disease or asthmatic status, it is better to give preference to the second. The bronchodilator has a combined composition and has a more persistent bronchodilator effect.

[ 2 ], [ 3 ]

Berodual or Salbutamol?

Salbutamol is an anti-asthmatic drug from the pharmacological group of beta-adrenergic receptor stimulants. It is used to treat bronchial asthma and chronic bronchitis. The drug is used by inhalation using a nebulizer or aerosol. The dosage of the drug and the duration of its use are determined by the attending physician.

Side effects include dilation of peripheral vessels, moderate tachycardia and muscle tremor. The drug is contraindicated in case of intolerance to its components. It is prescribed with caution in diseases of the thyroid gland, arterial hypertension, during pregnancy and lactation. It has several forms of release: tablets, syrup in bottles, solution and powder for inhalation.

Despite the fact that Berodual and Salbutamol are similar drugs, they have different effects on the body.

Benefits of Salbutamol:

• Can be used as an emergency aid for bronchospasms.
• In addition to treating respiratory diseases, it is used in gynecology.
• It comes in many forms, which simplifies the treatment process.
• Minimal side effects and contraindications.

Berodual for inhalation contains two active substances, so it requires a lower dosage compared to similar drugs. It is highly effective in the treatment of acute and chronic diseases of the bronchopulmonary system. It has clearly established contraindications and can cause side effects. The final decision on which drug should be used in a particular case is made only by the attending physician.

[ 4 ], [ 5 ], [ 6 ], [ 7 ]